The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 53 | — | 20.1x | Near average | |
Growth | 59 | — | 5.6% | Near average | |
Quality | 2 | -1200.9% | 7.6% | Below average | |
Safety | 48 | 0.7x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | 79 | — | — | Above average | |
Sentiment | 34 | — | — | Below average |
Achieve Life Sciences, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Achieve Life Sciences, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
ACHV stock has witnessed a radical shift in analyst optimism over the past 30 days, with the average price target jumping by 173.68% to rise from 4.75 to 13 dollars. This change is supported by a full Consensus among 6 analysts, as price differences have completely vanished (Dispersion = 0) with the low and high targets set at 13 dollars, reflecting unified institutional confidence in the stock's fair value compared to its current price of 4.45 dollars.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.